Peripheral blood lymphocytes express recombination-activating genes 1 and 2 during Epstein-Barr virus-induced infectious mononucleosis

J Infect Dis. 2004 Sep 1;190(5):979-84. doi: 10.1086/423211. Epub 2004 Jul 29.

Abstract

Implicit in the persistence of Epstein-Barr virus (EBV) in B lymphocytes is the successful circumvention of ongoing cell selection for competence of B cell receptors (BCRs). Because the EBV infection of B cells in vitro induces enzymatic machinery that is responsible for secondary immunoglobulin gene rearrangement, we examined the expression of the recombination-activating genes (RAGs) in peripheral blood mononuclear cells (PBMCs) from 26 patients with infectious mononucleosis (IM). RAG1 and/or RAG2 RNA was detected in PBMCs from 42% of patients with IM but not from healthy control subjects. EBV may usurp the cellular mechanism that diversifies the BCR, to guarantee a level of survival signaling sufficient for its own persistence.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism*
  • Epstein-Barr Virus Infections / virology
  • Female
  • Gene Expression Regulation
  • Genes, RAG-1 / genetics
  • Genes, RAG-1 / physiology*
  • Herpesvirus 4, Human / pathogenicity*
  • Humans
  • Infectious Mononucleosis / immunology
  • Infectious Mononucleosis / virology*
  • Leukocytes, Mononuclear / metabolism*
  • Leukocytes, Mononuclear / virology
  • Male
  • Nuclear Proteins
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism

Substances

  • DNA-Binding Proteins
  • Nuclear Proteins
  • RAG2 protein, human
  • RNA, Messenger
  • V(D)J recombination activating protein 2